The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...

In a report released yesterday, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

Stocks were mostly lower on Thursday after a disappointing business forecast from retail giant Walmart. Here, we look at the ...

Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...

The oft-maligned skinny jean has crept back onto the runway and is headed for a comeback as soon as this fall.

On Thursday, BTIG analyst Andrew Harte maintained a Buy rating on Paysafe stock (NYSE:PSFE) with a $26.00 price target. This affirmation came in the wake of reports from Bloomberg that Paysafe is ...

On Thursday, BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib ...